Related Experiment Video
Updated: Jun 11, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Engineered Probiotics Protect against Pseudomonas aeruginosa Post Antibiotic Exposure
Siyao Wang1,2, Baoyan Zhang1,2, Shuyi Zhang3,4
1Beijing Advanced Innovation Centre for Biomedical Engineering, Key Laboratory for Biomechanics and Mechanobiology of Ministry of Education, School of Engineering Medicine, Beihang University, Beijing 100083, P. R. China.
Abstract:
Broad-spectrum antibiotics profoundly disrupt the commensal microbiota and compromise mucosal immunity, creating a vulnerable postantibiotic window that predisposes hosts to opportunistic infections such as Pseudomonas aeruginosa. Strategies for restoring host homeostasis and stimulating mucosal immunity during this period remain limited. Here, we developed a modular and programmable probiotic strategy based on engineered Escherichia coli Nissle 1917 (EcN) that integrates metabolite replenishment with antigen-specific mucosal immunization. The butyrate-overproducing strain restored immune homeostasis after antibiotic exposure, enhanced baseline pulmonary neutrophil levels, and promoted bacterial clearance upon P. aeruginosa challenge. Additionally, synthetic EcN strains were engineered to release outer-membrane vesicles displaying P. aeruginosa antigens (PcrV or OprL), eliciting a robust pathogen-specific mucosal immunity. In antibiotic-exposed mice, metabolite and immunization modules independently reduced the pulmonary bacterial burden and improved survival following P. aeruginosa infection. Combined administration exerted synergistic protection, resulting in higher survival than the butyrate-overproducing strain alone under a lethal P. aeruginosa challenge. Together, this work establishes a versatile synthetic biology framework in which independently engineered probiotic modules can be flexibly combined to regulate microbiota function and deliver targeted immunotherapy, offering a promising alternative to antibiotic-dependent infection control.
Insights
Engineered probiotics can restore gut microbiota and immunity after antibiotics. This strategy combines metabolite replenishment and targeted immunization to combat opportunistic infections like Pseudomonas aeruginosa.
Area of Science:
- Microbiology
- Immunology
- Synthetic Biology
Background:
- Broad-spectrum antibiotics disrupt gut microbiota and mucosal immunity, increasing susceptibility to opportunistic pathogens like Pseudomonas aeruginosa.
- Limited strategies exist to restore host homeostasis and mucosal immunity during the vulnerable postantibiotic period.
Purpose of the Study:
- To develop a modular probiotic strategy using engineered Escherichia coli Nissle 1917 (EcN) for metabolite replenishment and antigen-specific mucosal immunization.
- To evaluate the efficacy of this strategy in restoring immune homeostasis and preventing opportunistic infections post-antibiotic treatment.
Main Methods:
- Engineered EcN strains to overproduce butyrate for immune restoration.
- Engineered EcN strains to display Pseudomonas aeruginosa antigens (PcrV or OprL) on outer-membrane vesicles for immunization.
- Administered engineered EcN strains to antibiotic-exposed mice and challenged with P. aeruginosa.
Main Results:
- The butyrate-producing EcN restored immune homeostasis, increased pulmonary neutrophils, and enhanced bacterial clearance.
- Antigen-displaying EcN elicited pathogen-specific mucosal immunity.
- Both metabolite and immunization modules independently reduced bacterial burden and improved survival; combined administration showed synergistic protection.
Conclusions:
- A versatile synthetic biology framework using modular engineered probiotics offers a promising approach to combat opportunistic infections.
- This strategy integrates metabolite replenishment and targeted immunotherapy for enhanced protection against postantibiotic infections.
- Flexible combination of probiotic modules provides a novel alternative to conventional antibiotic-dependent infection control.
Related Concept Videos
Probiotics
Microbiota Modulation by Antibiotics
Clinical Significance of Antibiotic Resistance
Production of Antibiotics
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Mechanism of Antibiotic Resistance in MRSA

